Lantern Pharma Inc. (LTRN) vs Tempest Therapeutics, Inc. (TPST)
A side-by-side comparison of Lantern Pharma Inc. and Tempest Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LTRN
Lantern Pharma Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TPST
Tempest Therapeutics, Inc.
$0.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LTRN vs TPST
growth of $100 · dividends reinvested · last 6yLTRN -93.7% (-36.9%/yr)TPST -99.8% (-65.3%/yr)LTRN compounded faster over this window
Log scale — wide-divergence pair
LTRN TPST
LTRN vs TPST: by the numbers
- •TPST is the larger company ($13M vs $12M market cap).
Metrics side by side
Profitability
| Metric | LTRN | TPST |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROIC | -358.04% | -784.16% |
Growth (annualized)
| Metric | LTRN | TPST |
|---|---|---|
| Total return CAGR (5Y) | -37.05% | -66.75% |
Frequently asked
- How have LTRN and TPST total returns compared?
- Over the past 5 years, LTRN delivered -37.05% and TPST delivered -66.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.